Pulmonary reactions to drugs are a significant clinical problem and serve as a model for lung injury owing to other causes. Pulmonary reactions to certain drugs, such as bleomycin, carmustine, and amiodarone, greatly limit the use of these drugs. If research can distinguish the toxic from the therapeutic mechanisms of these and other drugs perhaps more effective therapies can be designed.